Almanack Investment Partners, Llc. Novartis Ag Transaction History
Almanack Investment Partners, Llc.
- $570 Million
- Q1 2024
A detailed history of Almanack Investment Partners, Llc. transactions in Novartis Ag stock. As of the latest transaction made, Almanack Investment Partners, Llc. holds 2,964 shares of NVS stock, worth $320,289. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,964
Previous 2,894
2.42%
Holding current value
$320,289
Previous $292,000
2.05%
% of portfolio
0.05%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding NVS
# of Institutions
1,350Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.33 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$784 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$650 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$639 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...